methods two-group, randomized, controlled three week trial (august 2009-april 2010) conducted at a single academic center, involving 80 primarily female (70%) patients, mean age 47±18 with ibs diagnosed by rome iii criteria and with a score ≥150 on the ibs symptom severity scale (ibs-sss).